CHRD: A Transmembrane Protein Implicated in Neurodegenerative Diseases

Target Name: CHRD

NCBI ID: G8646

CHRD

CHRD: A Transmembrane Protein Implicated in Neurodegenerative Diseases

CHRD (CHRD variant 1) is a protein that is expressed in the brain and is known for its role in the development and progression of neurodegenerative diseases, such as Alzheimer's disease. It is a transmembrane protein that is composed of four intracellular domains: an N -terminus, a transmembrane domain, a protein-coding domain, and an C-terminus.

The N-terminus of CHRD contains a region that is similar to the N-terminus of the protein known as Calbindin, which is a protein that is expressed in the brain and is involved in the development and progression of neurodegenerative diseases. The transmembrane domain of CHRD is composed of a variable number of alpha helices and beta sheets, and is responsible for the protein's transmembrane properties and its ability to interact with other proteins.

The protein-coding domain of CHRD contains a single open reading frame (ORF) that is composed of a unique combination of amino acids that are involved in the regulation of neurotransmitter signaling, cell signaling, and neurotransmitter transport. The C-terminus of CHRD contains a region that is involved in the regulation of neurotransmitter signaling and is composed of a unique combination of amino acids that is involved in the regulation of neurotransmitter release and uptake.

CHRD is a protein that is expressed in the brain and is involved in the development and progression of neurodegenerative diseases. The N-terminus of CHRD contains a region that is similar to the N-terminus of the protein known as Calbindin, which is a protein that is expressed in the brain and is involved in the development and progression of neurodegenerative diseases. The transmembrane domain of CHRD is composed of a variable number of 伪 helices and 尾 twists, and is responsible for the protein's transmembrane properties and its ability to interact with other proteins. The protein-coding domain of CHRD contains a single open reading frame (ORF) that is composed of a unique combination of amino acids that are involved in the regulation of neurotransmitter signaling, cell signaling, and neurotransmitter transport. The C-terminus of CHRD contains a region that is involved in the regulation of neurotransmitter signaling and is composed of a unique combination of amino acids that is involved in the regulation of neurotransmitter release and uptake.

CHRD is a potential drug target for the treatment of neurodegenerative diseases, due to its involvement in the development and progression of these diseases. The N-terminus of CHRD contains a region that is similar to the N-terminus of the protein known as Calbindin, which is a protein that is expressed in the brain and is involved in the development and progression of neurodegenerative diseases. The transmembrane domain of CHRD is composed of a variable number of 伪 helices and 尾 twists, and is responsible for the protein's transmembrane properties and its ability to interact with other proteins. The protein-coding domain of CHRD contains a single open reading frame (ORF) that is composed of a unique combination of amino acids that are involved in the regulation of neurotransmitter signaling, cell signaling, and neurotransmitter transport. The C-terminus of CHRD contains a region that is involved in the regulation of neurotransmitter signaling and is composed of a unique combination of amino acids that is involved in the regulation of neurotransmitter release and uptake.

In conclusion, CHRD is a protein that is expressed in the brain and is involved in the development and progression of neurodegenerative diseases. The N-terminus of CHRD contains a region that is similar to the N-terminus of the protein known as Calbindin, which is a protein that is expressed in the brain and is involved in the development and progression of neurodegenerative diseases. The transmembrane domain of CHRD is composed of a variable number of 伪 helices and 尾 twists, and is responsible for the protein's transmembrane properties and its ability to interact with other proteins. The protein-coding domain of CHRD contains a single open reading frame (ORF) that is composed of a unique combination of amino acids that are involved in the regulation of neurotransmitter signaling, cell signaling, and neurotrans

Protein Name: Chordin

Functions: Dorsalizing factor. Key developmental protein that dorsalizes early vertebrate embryonic tissues by binding to ventralizing TGF-beta family bone morphogenetic proteins (BMPs) and sequestering them in latent complexes (By similarity)

The "CHRD Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CHRD comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets